Fortress Biotech, Inc. (NASDAQ:FBIOP) Short Interest Up 1,056.5% in December

Fortress Biotech, Inc. (NASDAQ:FBIOP) saw a significant growth in short interest in December. As of December 15th, there was short interest totalling 26,600 shares, a growth of 1,056.5% from the November 30th total of 2,300 shares. Based on an average trading volume of 18,600 shares, the short-interest ratio is presently 1.4 days.

Fortress Biotech Trading Up 7.7 %

FBIOP stock opened at $6.85 on Friday. The stock has a 50-day moving average price of $5.94 and a two-hundred day moving average price of $7.69. Fortress Biotech has a 1 year low of $4.86 and a 1 year high of $18.00.

Fortress Biotech Company Profile

Fortress Biotech, Inc, a biopharmaceutical company, develops dermatology, pharmaceutical, and biotechnology products in the United States. The company markets dermatology products, such as Qbrexza a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane capsules for severe recalcitrant nodular acne; Amzeeq for severe acne vulgaris; Zilxi, a topical foam; Exelderm cream and solution for topical use; Targadox an oral doxycycline drug for adjunctive therapy for severe acne; Luxamend; sulconazole nitrate cream and solution for tinea cruris and tinea corporis; and doxycycline hyclate tablet.